09 September 2012

IDFC resesrch- Top buys – Mid cap & small cap


Tech Mahindra
􀀹 Merger with Mahindra Satyam would create an entity with US$2.6bn in sales and 75,000 employees, put it on the global map for large
deals and improve growth prospects.
􀀹 Core competencies of the two firms complement each other (enterprise services of Satyam and TechM’s mobility expertise), creating
a formidable player in the fast-growing enterprise mobility business, a key area of investment for Fortune 500 companies.
􀀹 Valuations of ~10.8x FY13E EPS on pro forma earnings do not completely capture the improved growth prospects of the company.
Eicher Motors
􀀹 Best play on CVs; company poised to gain market share, driven by AB Volvo-validated products and frugal cost structure (efficiency
close to that of 2W names!!!)
􀀹 Offers superior growth visibility in a cyclical industry due to rising HCV market share (up in a weak market), resilient LMD and exports/
outsourcing.
􀀹 CY13/ CY14 to be blow-out years as MDEP project goes live, RE expands capacity, new CV platform hits market and new EM brand is
launched.
Petronet LNG
􀀹 Company to expand capacity 2x over the next two years (Dahej +5m tpa from 10m tpa currently; Kochi +5m tpa) and 2.5x in four
years (Gangavaram +5m tpa).
􀀹 Domestic gas volumes remain muted; demand to keep growing in double digits over the next decade (volumes to grow from ~11m
tpa currently to ~15m tpa by FY15 and ~18m tpa by FY17E).
􀀹 Pricing remains an issue, but with newer tranches of domestic supply coming in at higher prices, acceptability of higher prices would
rise. Slowing Japanese demand and global capacity additions could drive some moderation in spot LNG prices in the next five years.

IDFC: Top buys – Large cap


Bajaj Auto
􀀹 Structurally well-placed; presence in 40 countries with 2W, 3W and, very soon, 4Ws. Poised to benefit the most from uptrading, with
brands like Pulsar and Kawasaki in its stable.
􀀹 Better placed to handle competition. Derives 20% of volumes from the domestic 100cc executive segment; robust launches planned in
key brands to tackle competition.
􀀹 Potential of RE60 not captured in estimates; could be replacement for 3Ws as it caters to demands of both regulators and customers.
Exports to start in 3QFY13.
M&M
􀀹 UVs drive growth while tractors take a pause. XUV and Bolero drive growth in a weak market and mitigate impact of weak tractor demand.
􀀹 Recent recovery of monsoon reduces risk of a tractor collapse.
􀀹 Recent turnaround of Tech Mahindra positive for consolidated financials.
JPA
􀀹 Capex has peaked, gearing expected to reduce.
􀀹 Expect strong cash flows in power (JPVL) due to robust generation at hydro plants and progress of projects under construction. Yamuna
Expressway commissioned; to pave way for real estate launches in new locations along the expressway.
L&T
􀀹 Diversified skill-sets for a range of industries; vendor of choice for large and complex projects.
􀀹 Large and diversified order book.
􀀹 Captures maximum value from most orders due to broad presence in the value chain (e.g., power EPC solutions include manufacturing of
both BTG and BoP components).

Syndicate Bank ( TP : ` 145, Buy) 􀁹 :Dolat Capital, top pick


Syndicate Bank (CMP: ` 95, TP : ` 145, Buy)
􀁹 Syndicate Bank’s management plans to expand credit book faster than the industry, in the range of
18-19% and retail credit book would grow at even faster pace of 22%. Key focus area for credit
growth would be retail, MSME and mid-corporate. We expect credit book to grow 17.4% CAGR in
FY12-14. Faster expansion in retail and MSME books would aid asset yield and margin
􀁹 The bank plans to increase its CASA share by 100-125 bps to 32% mark. Also, re-pricing of bulk
deposits and CD at lesser rated would aid margin erosion in declining interest rate scenario.
􀁹 The bank’s management expects 15bps decline in margin to 3.25% from 3.4% in FY12. We factor in
10 bps decline in margin to 2.96% (on yearly average basis) primarily due to decline in interest rates
and re-pricing lag of liabilities
􀁹 On the back of higher loan growth and alignment of processing charges with peers, fee income is
expected to revive. We expect the bank’s other income to grow by 13% YoY in FY13
􀁹 As on June’12, the bank’s asset quality improved on sequential basis; further higher PCR provides
comfort for future NPL provisioning. The bank’s management expects to do a substantial recoveries
in FY13
􀁹 At current price, the stock quotes at 0.65x and 0.56x adjusted book value (ABV) FY13 and FY14
respectively. Based on our price target of ` 145, the stock will trade at 1.0x and 0.9x ABV FY13 and
FY14 respectively

Karur Vysya Bank (TP : ` 512, Buy) 􀁹:Dolat Capital, top pick


Karur Vysya Bank (TP : ` 512, Buy)
􀁹 Karur Vysya Bank’s better understanding of clienteles’ business domain and widespread
regional presence are the key strengths. Continued robust credit book expansion and
contained delinquencies have been key outcomes of the bank’s strengths
􀁹 We expect the bank’s credit book to expand e e pec e ba s c ed boo o e pa d by 28% cagr in FY12-14 much higher than the
industry. Key focus area would be retail trade, SME and agriculture sectors
􀁹 In Q1 FY13, KVB’s margin drifted by 22bps QoQ to 2.82% on higher cost of funds, however
going forward, moderation in deposit growth and increase in credit-deposit ratio would protect
erosion in margin. Though, the decline in CASA share remain our near term concern. We
factor margin to drift by 26bps to 2.62% (on yearly average basis), as a conservative stance
􀁹 We expect GNPA to hold in the current level even as the marginal pressure on asset quality
would be mitigated by higher recoveries and upgradations
􀁹 At current price, the stock quotes at 1.4x and 1.3x adjusted book value (ABV) FY13 and FY14
respectively. Based on our price target of ` 512, the stock will trade at 1.8x and 1.6x ABV
FY13 and FY14 respectively

HDFC Bank (TP : ` 627, ACC) 􀁹:Dolat Capital, top pick


HDFC Bank (TP : ` 627, ACC)
􀁹 HDBK’s diversified credit book with prudent expansion strategy has led to healthy yield and
minimal delinquencies. High low-costdeposits share contain erosion in margin and also aides
the bank to cross-sale its other products to huge low-cost depositors base. We expect credit
to expand faster than the system at CAGR of 21% over FY12-14
􀁹 Slight re-balancing in credit book in favor of high-yielding assets aided yield on advances
(mainly due to higher composition of retail loan book). Higher asset yield and expansion in CD
ratio aided margin. Going forward, we expect NIM to stabilize at 4.2% on yearly average
basis
􀁹 Majority of fee income comes from various retail segment and is quite diversified. Incremental
adverse impact on the bank’s fee income would be muted
􀁹 HDBK demonstrated robust performance on asset quality front; GNPA & restructured loan
book remained almost stagnant. The bank has been maintaining most comfortable asset
quality amongst the peer group with GNPA at 0.97% and NNPA at 0.2%. Total restructured
assets were 0.3% of the bank’s gross advances as of Q1 FY13
􀁹 At current price, the stock quotes at 4.0x and 3.4x adjusted book value (ABV) FY13E and
FY14E respectively. Based on our target price of ` 627, the stock would trade at 4.2x and 3.6x
ABV FY13E and FY14E respectively

ICICI Bank ( TP : ` 1,323, Buy):Dolat Capital, top pick


􀁹 ICICI Bank’s traction in business expansion, improvement in margin, reduction in credit cost
and decrease in leverage (with expansion in balance-sheet size) would yield higher return
ratios going forward
􀁹 We expect credit book to expand in high teens (e e pec c ed boo o e pa d g ee s 20% CAGR during FY12-14E) driven by SME,
retail & working capital requirements
􀁹 The bank would record NIM in a range of 2.8-2.9% on the back of higher yield on
investments, reduction in losses on securitized book, traction in overseas business and
stability in CASA deposit share
􀁹 We expect that the bank’s other income to grow by 17% CAGR over FY12-14E on the back of
healthy core fee income
􀁹 With tier I capital of 12.8% (as on end-June’12), the bank is adequately capitalized. The bank
would not be required to raise equity capital in near future
􀁹 The bank quotes at cheap valuations, hence offer an opportunity to add to the positions. At
current price, the stock quotes at 1.8x and 1.7x adjusted book value (ABV) FY13 and FY14
respectively. Based on our price target of ` 1,323, the stock will trade at 2.6x and 2.3x ABV
FY13 and FY14 respectively

Banking sector Q1 FY13 Review :Dolat Capital,


􀁹 In Q1 FY13, private sector banks demonstrated better performance on balance-sheet expansion,
stability of margin and asset quality fronts. On deposit mobilization front, each of the private sector
banks under coverage (barring ICICI Bank) recorded higher deposit growth than the industry and
state-ownedbanks.Smaller private sector posted much higher expansion indeposit base; among
state-owned banks, IOB, PNB and Andhra Bank were ahead of its peers
􀁹 Overall, banks’ deposit profile demonstrated weakening with decrease in CASA share. KVB and
Andhra Bank surprised with increase in CASA share even in such tight liquidity condition; in case of
KVB, current deposit mobilization significantly aided CASA share
􀁹 Private sector banks under coverage outshined state-owned banks and industry overall in credit
disbursements. Smaller private sector banks under coverage were better off due to their lower
bases. State-owned banks (under coverage) recorded lesser credit book expansion than the
industry overall. Canara Bank moderated its credit growth to further reduce dependence on
wholesale advances and short-term corporate loans on unsecuredbasis
􀁹 On asset quality front, PSU banks performance was quite dismal with sharp jump in gross slippage
ratio. SBI, UBI, Andhra Bank and BoI posted highest increase in slippages ratio on sequential basis.
IOB and OBC recorded sequential decline with higher base in Q4 FY12. Private sector banks were
better off on this front as well in our coverage universe
􀁹 Though, some of the state-owned banks (under coverage) reported higher credit cost on sequential
basis but not enough to maintain PCR. Most of banks under coverage reported sequential decrease
in PCR except for OBC, Syndicate Bank and ICICI Bank

Destimoney: Moderate Portfolio


Sector Company Model Portfolio Wt.
Agri 5.4%
Bayer Cropscience Ltd 5.4%
Auto 3.0%
Mahindra & Mahindra Ltd 3.0%
Capital Goods 2.8%
Larsen & Toubro Ltd 2.8%
Financials 14.4%
CRISIL Ltd 6.0%
Housing Development Finance 4.1%
State Bank Of India 4.3%
FMCG 31.6%
Asian Paints Ltd 5.0%
Hindustan Unilever Ltd 6.1%
ITC Ltd 7.5%
Jyothy Laboratories Ltd 4.0%
Procter & Gamble Hygiene 4.0%
Speciality Restaurants Ltd 5.0%
Logistics 4.0%
Blue Dart Express Ltd 4.0%
Pharma 13.5%
Glaxosmithkline Pharmaceuticals 5.1%
Merck Ltd 4.2%
Pfizer Limited 4.2%
Power 7.6%
NTPC Ltd 7.6%
Technology 3.9%
Tata Consultancy Svcs Ltd 3.9%
Cash 13.9%
100.0%

Destimoney: Conservative Portfolio


Sector Company Model Portfolio Wt.
Agri 5.6%
Bayer Cropscience Ltd 5.6%
Auto 3.0%
Mahindra & Mahindra Ltd 3.0%
Capital Goods 2.2%
Bharat Heavy Electricals 2.2%
Financials 16.3%
CRISIL Ltd 6.0%
HDFC 6.9%
State Bank Of India 3.3%
FMCG 24.4%
GSK Consumer Healthcare 5.4%
ITC Ltd 10.0%
Nestle India Ltd 6.3%
Trent Ltd 2.7%
Logistics 4.0%
Blue Dart 4.0%
Oil & Gas 3.2%
Gail India Ltd 3.2%
Pharma 11.8%
Aventis Pharma Ltd 4.5%
Cipla Ltd 2.9%
Merck Ltd 4.4%
Power 12.3%
NTPC Ltd. 5.2%
Power Grid Corporation 4.0%
Tata Power Co. Ltd. 3.1%
Technology 3.1%
Infosys Technologies Ltd. 3.1%
Cash 14.0%
100.0%

Destimoney: Aggressive Portfolio


Sector Company Model Portfolio Wt.
Agri 5.2%
Bayer Cropscience Ltd 5.2%
Auto 5.5%
Mahindra & Mahindra Ltd 3.0%
Tube Investments of India 2.5%
Capital Goods 2.8%
Larsen & Toubro Ltd 2.8%
Construction 2.0%
Sobha Developers Ltd 2.0%
Financials 8.0%
ICRA Ltd 5.5%
Punjab National Bank 2.5%
FMCG 38.0%
Asian Paints Ltd 5.0%
Dabur India Ltd 6.9%
Hindustan Unilever Ltd 4.6%
ITC Ltd 7.6%
Jyothy Laboratories Ltd 5.0%
Marico Ltd 4.0%
Speciality Restaurants Ltd 5.0%
Logistics 4.0%
Blue Dart Express Ltd 4.0%
Pharma 9.9%
Merck Ltd 4.1%
Pfizer Limited 5.8%
Technology 4.7%
Wipro Ltd 4.7%
Cash 20.0%
100.0%

Stock Strategy: Consider a bull call spread on RPower :: Business Line


Gold zooms 15%, stock wealth grows at snail's pace in 2012: moneycontrol

Gold has sparkled for investors, having given them handsome 15% returns in the past one year period to September, while contribution from stocks to their kitty has remained almost negligible during the same period. Also, the government and Reserve Bank have been urging investors recently to deploy their capital in instruments like stocks and mutual funds, rather than keeping them in idle assets like gold. Gold has appreciated from Rs 27,400 level in early September of 2011 to a record of over Rs 32,000 level at present. A comparative analysis of equity market trends shows that the combined investor wealth of all categories of shareholders across nearly 3,000 stocks has hardly budged from around Rs 62 lakh crore-mark in the 12-month period ended September 7. With savvy investors taking exposure of the stock market through mutual fund route as well, the stagnant prices of shares reflect in the net asset values of around half of the 350-odd equity funds which have failed to return even one per cent in the past one-year period. Interestingly, the Reserve Bank of India (RBI) earlier this month urged the public against choosing gold as an asset for savings or investment. "Because interest rates are very low, people are investing in gold. But the poor should never invest in gold for whenever they have purchased gold, it either lands up in the temple or in the hands of the moneylender or, at the most, it may be given away during a daughter's marriage," RBI Deputy Governor K C Chakrabarty had said. Prior to that, Finance Minister P Chidambaram as well last month favoured encouraging more people to invest in financial instruments rather than in gold, while urging the capital market regulator Sebi to consider fresh market reform measures for the benefit of investors. "More and more households should be encouraged to save in financial instruments rather than in gold," Chidambaram had said a day after Sebi's board on August 16 announced wide- ranging reforms for IPOs and mutual funds -- the two instruments aimed at attracting retail investors to market. However, the investors continue to remain enamoured by the glitter of gold. Even though certain duties on gold have increased post-Budget and rupee's weakness against the US dollar has added to the landed costs of imports, Indians' appetite for the yellow metal has seen it scaling new peaks almost every passing day in the recent past. Apart from notional gain made in investments in jewellery, money put in gold exchange traded funds has swelled by 14-15% as they closely track domestic prices of the yellow metal. In striking contrast, the Sensex is nearly 20% below its life-time high of 21,206.77 points hit in January, 2008 and most analysts see no immediate light at the end of the tunnel. The appetite for IPOs has remained tepid with nearly 50% of the new listings since September, 2011 trading below or close to issue prices. Gold's sparkle has not dimmed a bit after calendar year 2011 witnessed it trumping stocks with a solid 31% rise in prices while the volatile share market wiped off about 25% of investor wealth from January-December, 2011. The uninspiring performance of the stock market, however, hasn't seen any major reversal as yet. The 30-share blue-chip index BSE Sensex has inched just 500 points higher over the last 250-odd trading days so far from 17,200 levels to nearly 17,700 levels.

Higher MF expense ratio in new cities may be the game changer :: Business Line


Insure your house, your carpets too! :: Business Line


Home insurance breaks into two parts. The first part is the structure and the second is the things you have in your house.
Ever come across those advertisements offering to insure your home? Insurance for your home is meant simply to cover any damage or loss hitting your house.

Axis Bank: Retain Buy, cutting TP to INR1,200:Nomura research

Slower growth ahead

Action: Cutting TP to INR1,200 from INR1,400; retain Buy
We cut our target price on Axis Bank (AXSB IN) to INR1,200 from
INR1,400 on slower loan growth. We maintain our Buy rating. Our new TP
implies 2x FY13F ABV for an ROA of 1.4% and adjusted ROE of 19%.

Investment Focus - Shriram City Union Finance NCD: Invest :: Business Line


With interest rates on bank deposits beginning to dip sharply, non-convertible debentures (NCDs) from companies offer a good option for investors looking to lock into higher fixed returns. These are, however, suitable only for investors with some risk appetite, as they are not as safe as bank deposits.
For such investors, the three-year NCD option from Shriram City Union Finance appears a good bet. Shriram City is a deposit taking non-banking finance company that lends mainly to retail customers and small/medium enterprises. For individual investors, the yield on the cumulative option for investments of less than Rs 5 lakh is an attractive 11.5 per cent. For more than Rs 5 lakh investments, the yield offered is 10.6 per cent. For high net worth investors, there are better options in the market at that rate. The NCDs are secured.
The rates look compelling, especially in the light of some banks cutting their deposit rates. The rates on this secured option is 1.75 percentage points more than the highest rate offered by banks. The best rate offered by similarly rated NBFC deposits is 10.75 per cent.

ICICI Bank: Upgrade to Buy with a TP of INR1,165:Nomura research


Good loans are made in bad times


Action: Upgrade to BUY with a TP of INR1,165
We upgrade ICICI Bank to BUY, with a TP of INR1,165. In our view, ICICI
will be relatively better shielded from the asset quality deterioration
expected in the Indian banking sector over the next several quarters
thanks to its balance sheet consolidation during FY09-FY10. While other
banks were expanding their loan books at a rapid pace, ICICI did not take
aggressive exposure to sectors where asset quality is now suspect. Its
ROE (on the best capital base in the system), which was stuck in the 10-
12% range, is now expected to increase to 15% (consolidated) by FY13F,
driven by NIM expanding to 2.9% in FY13F from 2.7% in FY12,
decreasing LLPs and as capital returns from subsidiaries.


Impact of SEBI amendments on MF investors:: Business Line


The Mutual Fund Advisory Committee met with SEBI to bring some kind of equilibrium between the interests of investors and that of distributors, with a hope to channel growth of the Industry.
Following the meeting, SEBI has proposed a slew of measures (pending notification) to increase the participation of retail investors in the mutual fund industry. Here, we take a look at some important proposals and, if implemented, their impact on you as a mutual fund investor.

Prefer private banks; upgrading ICICI Bank ::Nomura research


Retail spend robust; private
banks better leveraged


The asset-quality hangover
Asset quality will separate the winners from the losers in the Indian
banking sector in the current cycle, in our view. We have seen relatively
higher NPL formation in the PSU banks than that in the private sector
banks, and we identify several reasons why the bad loan hangover will
persist for the PSU banks: relatively higher exposure to GNPL ‘heavy’
sectors, relative disadvantage in GNPL 'ageing' structure and low ex-loss
asset provision cover. We also highlight the activity at the corporate debt
restructuring cell.


Federal Bank:: Weak core performance :: Centrum


Weak core performance
FED’s Q1FY13 core performance came in weaker than expected (PPP at
Rs3.5bn vs Rs3.8bn estimated) led by 15bps NIM contraction QoQ and slightly
higher opex. However, bottomline was in line led by materially lower
provisioning costs. High slippage rate (3%) and significant addition to
restructured book (Rs2bn) for the quarter were disappointing. Given the
limited upside to our fair value estimate, we downgrade the stock to Reduce.
NIM contracts by 15bps QoQ: NII grew by a muted 7% yoy and flattish QoQ
to Rs4.9bn as NIM contracted by 15bps QoQ offsetting healthy credit growth
(19% YoY). Importantly, the NIM is the result of material dip in investment
yields (~40bps QoQ) while loan yields stood flattish QoQ. The normalisation of
NIM is likely to continue, led by gradually shifting the loan mix in favour of the
corporate segment (besides the sector-wide challenge of rising funding costs).
Corporate segment drives loan growth: Following the trend in recent
quarters, the corporate loan book continued to remain the key loan growth
driver as the management leveraged its equity further. Corporate loan growth
stood strong at 24% YoY compared with 15.6% for SME and 14% for the retail
segment. Importantly, the bank witnessed strong traction in gold loans (up
99% YoY and 18% QoQ), which resulted in an increase in the share of gold
loans in the overall loan mix to 11.2% from 9.5% in 4QFY12.

Growth driven by vaccines and derma products -Glaxo SK Pharma’s (GSK) :: Centrum


Growth driven by vaccines and derma products
Glaxo SK Pharma’s (GSK) results for Q2CY12 were in line with our
expectations. The company reported 15%YoY growth in revenues,
260bps decline in EBIDTA margin and 14%YoY growth in net profit.
The growth was driven by vaccines and derma segments, which grew
by ~25% each. GSK is a debt-free company with cash/share of Rs201.
We expect the growth momentum to be maintained due to good
growth from new products introduction. We have a Buy rating for the
scrip with a target price of Rs2,479 (based on 24x CY13E EPS of
Rs103.3).
Strong growth in core business: GSK reported 15%YoY growth in revenues
from Rs5.74bn to Rs6.62bn due to 16.3% growth in its core business. The
company’s vaccines and dermatology segments grew by ~25% each and are
expected to grow further due to new products introduction.
Margin declined due to currency effect: GSK’s EBIDTA margin declined by
260bps YoY from 34.7% to 32.1% due to sharp rise in the material cost. The
company’s material cost increased by 500bps from 35.9% to 40.9% of
revenues due to the rise in imported raw material cost and depreciating
rupee. GSK’s personnel cost declined by 160bps from 13.5% to 11.9% due to
higher sales growth. Other expenses declined by 80bps from 15.8% to 15.0%
of revenues.

Index Outlook - Bulls to press home the advantage :: Business Line


Why auctions are better than fixed-price sale :: Business Line

Picture this. You want to buy a sofa for your house. You can either buy the sofa from a fixed-price shop or you can bid for similar furniture at an auction. Assuming you like the furniture at the shop as well as the one at the auction, which would you prefer — fixed price or auction?

Sept 7: Top Movers : Business Line


Robust operational show; maintain buy -NMDC :: Centrum


Robust operational show; maintain buy
NMDC’s operational performance was above expectations in Q1FY13 with
EBITDA at Rs23bn (margin of 81%) as sales volume recovered QoQ and
remained stable YoY at ~6.9MT. Volume loss of ~1.7MT YoY from Essar’s
slurry pipeline was made up through sales from other means and higher sales
volume from Karnataka (~1.8MT, up YoY by ~30%). NMDC had hiked iron ore
prices for the quarter and blended realizations stood at ~Rs4140/tonne (up by
2.2% QoQ). NMDC is getting the benefit of the shift in its pricing mechanism
from export parity based to domestic demand-supply linked system. We see
stable pricing ahead due to favourable demand supply situation in domestic
market and also expect higher volume growth going ahead on expansion and
better logistics. We maintain our volume estimates and reiterate buy with a
target price of Rs227.
Volumes improve; pricing power becomes visible: Sales volumes stood at
~6.9MT, up ~7% QoQ and almost flat YoY as Karnataka sales volumes remained
stable sequentially at ~1.8MT and loss of volumes from Essar’s slurry pipeline (~1.7
MT in Q1FY12) were made up through sales to other customers and through other
means. Realizations remained strong at ~Rs4140/tonne as NMDC announced price
hikes and greater pricing power was seen for NMDC post the shift from export
parity based pricing to domestic demand supply linked pricing mechanism.
EBITDA margin improvement more than expected: EBITDA margin improved
smartly during the quarter and EBITDA stood at ~Rs23bn (margin at 81% and
EBITDA/tonne of Rs3358, up by ~9% QoQ) as realizations were higher due to price
hikes and costs were lower on operational improvements.

IIFL -Pair Strategy :: Long Dabur & Short ITC


Pair Strategy September 07, 2012
Long Dabur & Short ITC
Over the past six month, FMCG sector particularly ITC and HUL has
outperformed benchmark indices. In the initial part, rally in FMCG
had been limited to large cap companies. However, recently Mid-cap
companies such as Dabur and Marico has started to show positive
divergence vis-à-vis large cap. We believe this catch-up rally will
widen the historical price ratio between Dabur and ITC, from mean
to lower Band 2 at 1.90* (mean – 2nd standard deviation).
One year co-relation between Dabur and ITC is at 88% (strong
co-relation), while standard deviation at 0.111. We believe the
breakdown in historical price ratio from a six months support will
further drag the ratio lower.
We recommend traders to go long on Dabur (1 Lot September
futures) and short ITC (1 lot September futures) at price ratio of
2.04-2.05 with Stop loss placed at 2.12 for target of 1.90.

Sept 9:Technicals: SAIL, Monsanto, Ingersoll Rand, A2Z Maintenance, Welspun, Canara Bank:: Business Line


Sept 9:: Pivotals - Reliance Industries, SBI, Infosys, Tata Steel :: Business Line,


The best way to buy term insurance :: Business Line


Take a cover that factors in your future income and living expenses. Go for as long a tenure as possible. Buy online. And don’t go overboard with the riders.
Insurance companies offer a confusing range of products, with fancy names and many bells and whistles. But the most important type of insurance you should buy is still the plain term cover. It comes pretty cheap, too.
But do you just buy one? What are the main things you should know while buying a term policy?
You need to be aware of factors such as what the insurance policy actually covers, the amount you need, premium rates, riders, medical tests, tax benefits and the mode of buying, among other things. You should also know the fine-print aspects such as splitting amount across policies.

Talwalkars Better Value Fitness Buy Target Price: Rs219 ::Centrum


Talwalkars Better Value Fitness
Buy
Target Price: Rs219
CMP: Rs149         
Upside: 47%
Raring to go
m  Industry in a sweet spot: Fitness and slimming market is Rs40bn industry and is set to grow by 18.9% to Rs80bn over 3 years with fitness services such as gymnasium comprising 50% of this market (Rs20bn). It is an under-penetrated market with less than 5% penetration of the urban population. Key growth drivers being i) increasing young population ii) booming middle class with growing discretionary spends iii) growing number of lifestyle diseases and iv) increasing realization of a need for healthy lifestyles.